Genetically engineered and synthetic vaccines and diagnostics are being developed in many laboratories. Special attention has been paid to the influenza viruses, because detailed information on the structure, function and antigenic properties of the two influenza virus surface glycoproteins, haemagglutinin (H) and neuraminidase (N), is available (Ward, 1981; Wilson et al., 1981 ; Colman et al., 1983) . In the present series of experiments the sequence ser-91 to leu-108 of HA-1 which is common to at least 12 H3N2 influenza virus strains (Arnon & Shapira, 1984) was tested for immunogenicity. According to Wilson et al. (1981) this region contains a folded corner in the three-dimensional structure of H and it is adjacent to antigenic site D. The same sequence was selected for similar experiments by Mfiller et al. (1982) and was also investigated by Wilson et al. (1984) .
Two batches of the peptide were prepared. To prevent the dimerization of the peptide through S-S bonding, cysteine at position 97 was substituted by either methionine (batch denoted OP-1) or alanine (OP-2). Both peptides were synthesized by the standard solid-phase methodology (Barany & Merrifield, 1980) . The crude peptides were purified by reversed-phase HPLC. For immunization, peptides were coupled to purified tetanus toxoid (TT) (Sevac Prague) by means of either 1-ethyl-3-(3'-dimethyl-aminopropyl)-carbodiimide hydrochloride or glutaraldehyde. For serological reactions, peptides were coupled to bovine serum albumin (BSA) using glutaraldehyde. Rabbits were immunized by subcutaneous injections of 1 mg of conjugate dissolved in 0.5 ml of phosphate-buffered saline and mixed with an equal volume of Freund's complete adjuvant for the first dose and incomplete adjuvant for the subsequent five doses administered at 2 to 3 week intervals. The immunoglobulin fraction was isolated from each serum specimen using caprylic acid precipitation (Steinbuch & Audran, 1969) . The antibody response in these rabbits was monitored by solid-phase radioimmunoassay (SPRIA), haemagglutination inhibition and a neutralization test. SPRIA was performed using the procedure described by Such/mkovfi et al. (1984) . The following preparations were used as 0000-7581 © 1987 SGM Short communication (Brand & Skehel, 1972) , and (iii) 0.5 ~tg per well of virions purified according to Laver (1964) . Various dilutions (starting at 1 : 10) of the Ig preparations were tested. The reaction was considered positive if the ratio of c.p.m, of test serum to c.p.m, of preimmune serum was 2.0 or more. The immunization procedure and the development of antibodies reactive with the synthetic peptides (OP-1 or OP-2) and H of H3N2 virus are shown in Table t . It can be seen that antibodies reactive with either OP or with both OP and H developed in all rabbits. Two of the three rabbits which did not develop anti-H reactivity had been immunized with a preparation not purified by HLPC; this suggests a lower immunogenicity of this preparation. No marked differences in the immunogenic activity of OP-1 and OP-2 were encountered and no marked influence on the immune response was produced by the coupling procedure used. The antipeptide antibodies were nearly always detected earlier and attained higher levels than those reactive with H. This might be associated with the higher number of antibody-binding sites in the wells coated with the peptide than those coated with H. Alternatively the differential reactivity may have been due to a heterogeneity of the OP preparation which might consist of molecules possessing the conformation of the native protein as well as molecules with other conformations and antigenicities; thus antibodies capable of reacting with antigens present in OP preparations but not in H might have developed.
The reactivity in SPRIA of selected sera of OP-immunized rabbits with purified H and complete virions of homotypic and heterotypic influenza viruses are shown in Fig. 1 and 2 . The antibody was reactive with H preparations from H3N2 viruses but not with those derived from H1N1 and H2N2 viruses (Fig. 1) . These results, demonstrating specificity of the reaction of OPinduced antibodies, were in sharp contrast to the cross-reactivity observed when whole virions were used as antigens (Fig. 2) . Sera from the other OP-immunized rabbits reacted in the same way. The nature of the heterotypic reactions with whole virion antigens, also observed by another group of investigators (Arnon & Shapira, 1984) is not understood at this time.
In further tests the Ig (diluted 1:2, 1:4 and 1:8) from rabbit sera proved negative in haemagglutination inhibition tests (Tu6kov(t et al., 1968) and in a sensitive modification of the neutralization test in chick embryos using 1 and 10 EIDs0 of H3N2 Victoria/75 virus. Using OP a s antigen we also examined a group of 27 human sera and seven rabbit immune sera in SPRIA. Human sera were collected from healthy subjects vaccinated with a subunit influenza vaccine (Subinvira, Imuna, Czechoslovakia) containing H3N2 and H1N 1 viruses or unvaccinated, as well as from subjects experiencing a recent H3N2 virus infection. All of them contained homotypic haemagglutination inhibiting antibody ranging in titre from 1:20 to 1:5120. Sera originated from rabbits immunized with various complete H3N2 and H 1 N 1 viruses or purifiedpreparations from the same viruses. The homotypic HI antibody titres of these sera varied from 1:256 to 1:2560. Neither human nor rabbit sera gave a positive reaction in SPRIA with OP.
Finally, the capability of OP to confer protection in mice was examined. Mice were immunized intraperitoneally with 50~tg of the OP-1-TT conjugate in complete Freund's adjuvant. Two additional doses (each comprising 25 gg of the conjugate) in incomplete Freund's adjuvant were injected subcutaneously at 3-week intervals. One week after the third dose pooled sera were examined for antibody; only mice immunized with OP-1-TT were reactive with OP and H of H3N2 virus. At the same time the remaining animals were challenged intranasally with 106 EID of H3N2 Aichi/68 virus which replicated well in mouse lungs but did not kill the animals. Three days later their lungs were removed and individually tested for infectivity in embryonated eggs. Replication of the virus in immunized mice was comparable to that in the control mice (data not shown). These data are inconsistent with the recent observations by Shapira et al. (1985) which suggested a protective activity of the same synthetic peptide in mice.
In accordance with Mfiller et al. (1982) the present data indicate that a synthetic octadecapeptide corresponding to the sequence ser-91 to leu-108 of the HA-1 subunit of H3N2 is capable of inducing antibodies reactive with immunizing peptide and homotypic H preparations. However, both the serological data and experiments in mice suggest that the immune reactions are not of any significance for protection against infection. We also did not detect antibodies reactive with OP in SPRIA in any sera from humans who had experienced natural infection and/or immunization with split H3N2 vaccine or in sera of animals immunized with H preparations or complete virions of different influenza A viruses. This indicates that the region of HA-1 corresponding to OP is not immunogenic under conditions of natural infection or immunization with the more complex virus materials.
